The PFF Scholars program focuses on engaging early-career investigators in their emerging research in the field of pulmonary fibrosis. With the goal of advancing research that could translate into successful therapies for PF, the PFF Scholars program is designed to support and enable promising researchers to obtain independent funding and continue their cutting- edge research. Scholars will receive up to $50,000 over a two-year period.

Sarah O’Beirne, PhD

Apr 21, 2021, 09:12 AM
Title : Sarah O’Beirne, PhD
First Name : Sarah
Middle Name :
Last Name : O'Beirne, PhD
Position :
University : Joan & Sanford I. Weill Medical College of Cornell University
Proposal Title :
Proposal Funder : Boehringer Ingelheim Pharmaceuticals, Inc
Dr. O’Beirne, MD, PhD is an Assistant Professor in the Department of Genetic Medicine and Division of Pulmonary and Critical Care Medicine at Weill Cornell Medicine. She received her MD from National University of Ireland, Galway and Translational PhD from University College Dublin, Ireland where she studied the role of epithelial to mesenchymal transition in idiopathic pulmonary fibrosis. She completed her internal medicine residency and pulmonary fellowship through the Royal College of Physicians of Ireland, followed by a pulmonary and critical care fellowship in New York Presbyterian Hospital/Weill Cornell Medicine. Since completing her fellowship, Dr. O’Beirne has been undertaking translational pulmonary research in the Department of Genetic Medicine, Weill Cornell Medicine focused on the effects of exposures including tobacco smoke and ambient pollution on the airway epithelium and alveolar macrophage transcriptome, and the consequences of its dysregulation in the pathogenesis of chronic obstructive pulmonary disease. Her current research utilizes single cell RNA-sequencing to study interstitial lung diseases including hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.
Load more comments
Comment by from